Acute Stroke Clinical Trial
— BETASOfficial title:
Safety of Beta-hCG + Erythropoietin in Acute Stroke
The purpose of this study is to assess the safety of Beta-hCG + Erythropoietin in patients with acute ischemic stroke.
Status | Completed |
Enrollment | 12 |
Est. completion date | March 2008 |
Est. primary completion date | March 2008 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 21 Years to 85 Years |
Eligibility |
Inclusion Criteria: 1. Age 21-85 2. NIHSS score 6-24 at time of enrollment, ensuring that stroke is neither mild nor devastating 3. Stroke is ischemic in origin, supratentorial, and radiologically confirmed 4. Patient is 24-48 hours from time of stroke onset at time that first dose of B-E therapy is administered. Time of onset is when symptoms began, and stroke occurred during sleep, time of onset is when patient was last seen to be normal. 5. Reasonable expectation of availability to receive the full 9 day B-E therapy course 6. Reasonable expectation that patient will receive standard post-stroke physical, occupational, speech, and cognitive therapy as indicated Exclusion Criteria: 1. Pre-existing and active major psychiatric or other neurological disease 2. History of significant alcohol or drug abuse in the prior 3 years 3. Serum hemoglobin > 16 g/dL in a male patient or > 14 g/dL in a female patient; or a platelet count > 400,000/mm3 in either a male or female patient 4. Advanced liver, kidney, cardiac, or pulmonary disease; the former will be operationally defined as a serum bilirubin > 4 mg/dL, alkaline phosphatase > 250 U/L, SGOT > 150 U/L, SGPT >150 U/L, or creatinine > 3.5 mg/dL 5. Pregnancy or lactating; note that a negative pregnancy test will be required if the patient is a female in reproductive years, using a test that reliably detects beta-hCG levels > 25 with normal levels being < 8 IU/L. 6. Contraindication to study participation on the basis of any of the following: 1. Allergy or other contraindication to initiating either beta-hCG or Erythropoietin 2. Known hypersensitivity to mammalian cell-derived products or hypersensitivity to albumin 3. A known diagnosis of prostatic cancer; note that prostate specific antigen will be collected for retrospective assessment of safety, but will not be used to ascertain study eligibility 4. Dysuria of unexplained origin 5. Uncontrolled hypertension, defined in the context of acute stroke as blood pressure persistently above 220 mm Hg systolic or 120 diastolic despite antihypertensive therapy 7. Current use of either beta-hCG or Erythropoietin 8. Other condition known to elevate beta-hCG, active in the prior 24 months, e.g., choriocarcinoma or germ cell tumor 9. Terminal medical diagnosis consistent with survival < 1 year 10. Known hypercoagulable state, which for the purposes of this study will deficiency of proteins C, S, or antithrombin III; activated protein C resistance; prothrombin gene mutation; or an anti-phospholipid antibody syndrome as based on clinical and laboratory measures. |
Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United States | University of California, Irvine Medical Center | Orange | California |
Lead Sponsor | Collaborator |
---|---|
University of California, Irvine | Hoag Memorial Hospital Presbyterian, Stem Cell Therapeutics Corp. |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Safety | 3 mo | Yes | |
Primary | morbidity | 3 mo | Yes | |
Primary | mortality | 3 mo | Yes | |
Secondary | Action Research Arm Test | 3 mo | Yes | |
Secondary | Fugl-Meyer arm and leg motor scales | 3 mo | Yes | |
Secondary | Boston Naming Test | 3 mo | Yes | |
Secondary | Line Cancellation Test | 3 mo | Yes | |
Secondary | NIH Stroke Scale | 3 mo | Yes | |
Secondary | Geriatric Depression Scale | 3 mo | Yes | |
Secondary | Barthel Index | 3 mo | Yes | |
Secondary | Infarct volume using anatomical MRI | 3 mo | Yes | |
Secondary | Trail Making A & B tests | 3 mo | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03281590 -
Stroke and Cerebrovascular Diseases Registry
|
||
Enrolling by invitation |
NCT06074081 -
Comparison of 4-weeks of Motor Relearning Program and Mirror Therapy in Improving Upper Limb Motor Function in Stroke Patients.
|
N/A | |
Terminated |
NCT04039178 -
Efficacy of EMF BCI Based Device on Acute Stroke
|
N/A | |
Completed |
NCT04521634 -
Glycaemic Variability in Acute Stroke
|
||
Completed |
NCT03477188 -
The Effects of Somatosensory and Vestibular Rehabilitation Additional Conventional Therapy on Balance in Patients With Acute Stroke.
|
N/A | |
Recruiting |
NCT05065216 -
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
|
Phase 2/Phase 3 | |
Recruiting |
NCT02677415 -
Impact of Anesthesia Type on Outcome in Patients With Acute Ischemic Stroke (AIS) Undergoing Endovascular Treatment
|
N/A | |
Recruiting |
NCT01541163 -
Heart and Ischemic STrOke Relationship studY
|
N/A | |
Completed |
NCT01210729 -
Mechanical Recanalization With Flow Restoration in Acute Ischemic Stroke
|
Phase 2 | |
Recruiting |
NCT00785343 -
Study of Robot-assisted Arm Therapy for Acute Stroke Patients
|
Phase 1 | |
Completed |
NCT04779710 -
How Does Dysphagia Assessment in Acute Stroke Affect Pneumonia?
|
||
Active, not recruiting |
NCT03635749 -
Intensive Medical Therapy for High-risk Intracranial or Extracranial Atherosclerosis
|
Phase 3 | |
Recruiting |
NCT06149754 -
BraiN20® Monitoring in Acute Stroke Undergoing Thrombectomy
|
||
Recruiting |
NCT04491695 -
Tirofiban for the Prevention of Neurological Deterioration in Acute Ischemic Stroke
|
Phase 2/Phase 3 | |
Recruiting |
NCT04283760 -
Investigation of the Reliability and Validity of the Movement Imagination Questionnaire - Revised Second in Acute Stroke Patients
|
||
Recruiting |
NCT05454397 -
A Study on the Status of Nutritional Risk Screening and Nutritional Therapy in Neurology Hospitalized Stroke Patients
|
||
Completed |
NCT04488692 -
Early Functional Training in Acute Stroke Inpatient Ward
|
N/A | |
Recruiting |
NCT04214522 -
Reliability and Validity of the Kinesthetic and Visual Imagery Questionnaire in Acute Stroke Patients
|
||
Not yet recruiting |
NCT04157231 -
Essential Acute Stroke Care in Low Resource Settings: a Pilot studY
|
N/A | |
Recruiting |
NCT05469438 -
IMAS Optimization and Applicability in an Acute Stroke Setting.
|